🍂 Enjoy the Fall Season! 🍂
MindTheDesk

China’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial

Global - Asia Archived • August 26, 2026 • 2 views
China’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial
Chinese biopharmaceutical firm Akeso announced on Wednesday that its immunotherapy drug had outperformed AstraZeneca’s Imfinzi in a head-to-head phase-three trial for biliary tract cancer.
The result represents another breakthrough for Akeso’s ivonescimab – which has already been licensed by the US firm Summit Therapeutics in a multibillion-dollar deal – as China’s biopharma industry increasingly looks to compete on the global stage.
The Chinese trial tested ivonescimab and chemotherapy against...
Source: South China Morning Post | https://www.scmp.com/rss/91/feed - Read Original
"Get your business promoted today."

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Free Quote Today"
"We build AI or anything ICST"